• home
  • about us
    • the advantage
    • key facts
    • where we are
    • where we invest
    • management team
    • funds
  • portfolio
    • companies
    • CEOs
  • news
  • investments
    • focus
      • prevention & nutraceuticals
      • medical foods OTC, Rx
      • enabling technologies
      • brands & channels
      • diagnostics
    • criteria
    • process
  • your business
  • careers
  • contact us
    • the bahamas
    • united kingdom
    • china
    • new zealand

portfolio

Atonomics

Atonomics has developed a breakthrough point of care diagnostic device based on an innovative electro-mechanical concept. This technology will revolutionize the way that DNA and antibodies are used in point of care diagnosis.

Atonomics Achieves Significant Milestone Related to Performance Data for Troponin I Assay Triggering Scheduled Payments From Beckman Coulter
2012-11-26
  • Atonomics A/S announced today that it has achieved an important milestone related to a defined set of performance criteria for a Troponin I assay on the new Atolyzer® system.
  • "We expect that this recent and significant achievement will generate appropriate interest from Industry in order to reach the full potential of the Atolyzer® platform", said Ashok Dhanrajgir, Chairman of Atonomics board of directors and senior partner with Inventages Venture Capital.

Read the full article...

Thomas Warthoe, Atonomics:
 "Atonomics' vision and Inventages' early investment emphasize our common belief that new and improved technology can and will impact positively quality of life for most people."
www.atonomics.com
www.atonomics.com
Back to portfolio ...
Paul Hartung, Cognoptix
Paul Hartung, Cognoptix:
"Inventages has been a strong supporter in realizing the Cognoptix vision." More...
Terms Print Top
© 2013 Inventages